118 related articles for article (PubMed ID: 21047547)
1. Deoxycholate hydrogels of betamethasone-17-valerate intended for topical use: In vitro and in vivo evaluation.
Senyiğit T; Tekmen I; Sönmez U; Santi P; Ozer O
Int J Pharm; 2011 Jan; 403(1-2):123-9. PubMed ID: 21047547
[TBL] [Abstract][Full Text] [Related]
2. Comparative permeation studies of nondiluted and diluted betamethasone-17-valerate semisolid formulations through isolated human stratum corneum and artificial skin construct.
Mitriaikina S; Muller-Goymann CC
Skin Pharmacol Physiol; 2009; 22(3):142-50. PubMed ID: 19246962
[TBL] [Abstract][Full Text] [Related]
3. Nanostructured lipid carriers (NLC) based topical gel of flurbiprofen: design, characterization and in vivo evaluation.
Han F; Yin R; Che X; Yuan J; Cui Y; Yin H; Li S
Int J Pharm; 2012 Dec; 439(1-2):349-57. PubMed ID: 22989987
[TBL] [Abstract][Full Text] [Related]
4. Deoxycholate-hydrogels: novel drug carrier systems for topical use.
Valenta C; Nowack E; Bernkop-Schnürch A
Int J Pharm; 1999 Aug; 185(1):103-11. PubMed ID: 10425370
[TBL] [Abstract][Full Text] [Related]
5. Preclinical Assessment of Steroidal Nanostructured Lipid Carriers Based Gels for Atopic Dermatitis: Optimization and Product Development.
Nagaich U; Gulati N
Curr Drug Deliv; 2018; 15(5):641-651. PubMed ID: 28925874
[TBL] [Abstract][Full Text] [Related]
6. Comparison of PLGA and lecithin/chitosan nanoparticles for dermal targeting of betamethasone valerate.
Özcan I; Azizoğlu E; Senyiğit T; Özyazici M; Özer Ö
J Drug Target; 2013 Jul; 21(6):542-50. PubMed ID: 23390922
[TBL] [Abstract][Full Text] [Related]
7. In vitro release and antiinflammatory activity of topical formulations of ketoprofen.
Moretti MD; Gavini E; Peana AT
Boll Chim Farm; 2000; 139(2):67-72. PubMed ID: 10920531
[TBL] [Abstract][Full Text] [Related]
8. Enhanced dermal delivery of diflucortolone valerate using lecithin/chitosan nanoparticles: in-vitro and in-vivo evaluations.
Özcan I; Azizoğlu E; Senyiğit T; Özyazıcı M; Özer Ö
Int J Nanomedicine; 2013; 8():461-75. PubMed ID: 23390364
[TBL] [Abstract][Full Text] [Related]
9. Pluronic lecithin organogel as a topical drug delivery system.
Pandey M; Belgamwar V; Gattani S; Surana S; Tekade A
Drug Deliv; 2010 Jan; 17(1):38-47. PubMed ID: 22747074
[TBL] [Abstract][Full Text] [Related]
10. [Determination of drug availability from commercial topical formulations with a multilayer membrane model].
Neubert R; Winter K; Bendas B
Pharmazie; 1993 Jan; 48(1):54-6. PubMed ID: 8460175
[TBL] [Abstract][Full Text] [Related]
11. Palm Olein Emulsion: a Novel Vehicle for Topical Drug Delivery of Betamethasone 17-Valerate.
Ahmad K; Win T; Jaffri JM; Edueng K; Taher M
AAPS PharmSciTech; 2018 Jan; 19(1):371-383. PubMed ID: 28744617
[TBL] [Abstract][Full Text] [Related]
12. Formulation and evaluation of once-a-day transdermal gels of diclofenac diethylamine.
Baboota S; Shakeel F; Kohli K
Methods Find Exp Clin Pharmacol; 2006 Mar; 28(2):109-14. PubMed ID: 16636721
[TBL] [Abstract][Full Text] [Related]
13. Dermatopharmacokinetics of betamethasone 17-valerate: influence of formulation viscosity and skin surface cleaning procedure.
Wiedersberg S; Leopold CS; Guy RH
Eur J Pharm Biopharm; 2009 Feb; 71(2):362-6. PubMed ID: 18940255
[TBL] [Abstract][Full Text] [Related]
14. Pharmacodynamics and dermatopharmacokinetics of betamethasone 17-valerate: assessment of topical bioavailability.
Wiedersberg S; Naik A; Leopold CS; Guy RH
Br J Dermatol; 2009 Mar; 160(3):676-86. PubMed ID: 18782322
[TBL] [Abstract][Full Text] [Related]
15. Topical corticosteroid in foam vehicle offers comparable coverage compared with traditional vehicles.
Feldman SR; Sangha N; Setaluri V
J Am Acad Dermatol; 2000 Jun; 42(6):1017-20. PubMed ID: 10827406
[TBL] [Abstract][Full Text] [Related]
16. Archaeosomes as carriers for topical delivery of betamethasone dipropionate: in vitro skin permeation study.
González-Paredes A; Manconi M; Caddeo C; Ramos-Cormenzana A; Monteoliva-Sánchez M; Fadda AM
J Liposome Res; 2010 Dec; 20(4):269-76. PubMed ID: 19954402
[TBL] [Abstract][Full Text] [Related]
17. Formulation and evaluation of a proniosome hydrocortisone gel in comparison with a commercial cream.
Sankar V; Praveen C; Prasanth KG; Srinivas CR; Ruckmann K
Pharmazie; 2009 Nov; 64(11):731-4. PubMed ID: 20099517
[TBL] [Abstract][Full Text] [Related]
18. Phycocyanin liposomes for topical anti-inflammatory activity: in-vitro in-vivo studies.
Manconia M; Pendás J; Ledón N; Moreira T; Sinico C; Saso L; Fadda AM
J Pharm Pharmacol; 2009 Apr; 61(4):423-30. PubMed ID: 19298687
[TBL] [Abstract][Full Text] [Related]
19. Nanoencapsulation of betamethasone valerate using high pressure homogenization-solvent evaporation technique: optimization of formulation and process parameters for efficient dermal targeting.
Md S; Kuldeep Singh JKA; Waqas M; Pandey M; Choudhury H; Habib H; Hussain F; Hussain Z
Drug Dev Ind Pharm; 2019 Feb; 45(2):323-332. PubMed ID: 30404554
[TBL] [Abstract][Full Text] [Related]
20. Development of an in vitro skin permeation model simulating atopic dermatitis skin for the evaluation of dermatological products.
Simonsen L; Fullerton A
Skin Pharmacol Physiol; 2007; 20(5):230-6. PubMed ID: 17587887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
